2021
DOI: 10.1002/cbf.3670
|View full text |Cite
|
Sign up to set email alerts
|

The critical role of mesenchymal stromal/stem cell therapy in COVID‐19 patients: An updated review

Abstract: New coronavirus disease 2019 , as a pandemic disaster, has drawn the attention of researchers in various fields to discover suitable therapeutic approaches for the management of COVID-19 patients. Currently, there are many worries about the rapid spread of COVID-19; there is no approved treatment for this infectious disease, despite many efforts to develop therapeutic procedures for COVID-19. Emerging evidence shows that mesenchymal stromal/stem cell (MSC) therapy can be a suitable option for the management of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 135 publications
(196 reference statements)
0
0
0
Order By: Relevance